Lannapril

Ramipril, the active ingredient in Lannapril, is an ACE inhibitor presented as a tablet for oral use. It lowers blood pressure and is used to treat hypertension, heart failure, and to improve outcomes after myocardial infarction in adult patients.

GNH USA supplies Lannapril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows strict quality standards and provides regulatory‑approved batches to meet global demand.

Lannapril (ramipril) is employed in the management of cardiovascular conditions that involve the renin‑angiotensin system.

- Hypertension: reduces systolic and diastolic blood pressure, decreasing the risk of stroke and heart attack. - Heart failure: improves ventricular function and lowers mortality in patients with reduced ejection fraction. - Post‑myocardial infarction: decreases the likelihood of subsequent cardiovascular events and supports cardiac remodeling.

Ramipril may cause a range of adverse reactions, which are generally categorized by frequency.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially after the first dose. - Headache. - Fatigue. - Mild hypotension. - Elevated serum potassium.

Serious or Rare Side Effects: - Angioedema: swelling of lips, tongue, or airway. - Severe hypotension leading to syncope. - Acute renal impairment or failure. - Hyperkalemia with cardiac arrhythmia risk. - Neutropenia or leukopenia. - Hepatic dysfunction with jaundice.

Before initiating therapy, clinicians should evaluate patient history and monitor relevant parameters.

- Blood pressure monitoring: check for excessive drops after starting treatment. - Renal function: assess serum creatinine and eGFR periodically. - Serum potassium: monitor especially when combined with potassium‑sparing agents. - History of angioedema: avoid in patients with prior episodes. - Pregnancy: discontinue if pregnancy is confirmed unless benefits outweigh risks. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ramipril can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Aliskiren: combined renin‑angiotensin blockade may cause renal dysfunction. - Potassium‑sparing diuretics or supplements: increase risk of hyperkalemia. - Lithium: may raise lithium levels and cause toxicity. - NSAIDs (e.g., ibuprofen, naproxen): can impair renal function and blunt antihypertensive effect.

Moderate Interactions (Monitor Closely): - Loop or thiazide diuretics: may cause initial hypotension; adjust dose as needed. - Other antihypertensives (beta‑blockers, calcium channel blockers): additive blood‑pressure lowering effect. - Antidiabetic agents: may enhance hypoglycaemia; monitor glucose control.